Aspirin, salicylate and gastrointestinal injury.
Fernández
A G
AG
Salcedo
C
C
Palacios
J M
JM
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001120:Arginine / Q000031:analogs & derivatives / Q000627:therapeutic use; D001241:Aspirin / Q000009:adverse effects*; D003902:Detergents / Q000627:therapeutic use*; D005753:Gastric Mucosa / Q000098:blood supply / Q000187:drug effects* / Q000473:pathology; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced* / Q000517:prevention & control; D005782:Gels; D007413:Intestinal Mucosa / Q000098:blood supply / Q000187:drug effects* / Q000473:pathology; D009093:Mucus / Q000187:drug effects; D019331:NG-Nitroarginine Methyl Ester; D009569:Nitric Oxide / Q000502:physiology; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D010743:Phospholipids / Q000627:therapeutic use*; D051381:Rats; D012459:Salicylates / Q000009:adverse effects*; D013276:Stomach Ulcer / Q000139:chemically induced* / Q000517:prevention & control
D000894:Anti-Inflammatory Agents, Non-Steroidal; D003902:Detergents; D005782:Gels; D010743:Phospholipids; D012459:Salicylates; D009569:Nitric Oxide; D001120:Arginine; D019001:Nitric Oxide Synthase; D001241:Aspirin; D019331:NG-Nitroarginine Methyl Ester